Search Results

• • 1,036 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Processing of IVIg can affect its safety, efficacy: unwanted side effects

  Author:Jeff EvansFrom:Family Practice News (Vol. 34, Issue 9)

  May 1, 2004553 words Article WASHINGTON -- The inherent variability in the quality of current intravenous immunoglobulin products can lead to unwanted side effects, especially in patients who are vulnerable to the treatments" adverse events,...

• Current best evidence from dermatology literature - Part I

  Authors:Sonia Mangal and Muthu KumaranFrom:Indian Journal of Dermatology, Venereology, and Leprology (Vol. 79, Issue 6) Peer-Reviewed

  November-December 20133,893 words Report 1310LByline: Sonia. Mangal, Muthu. Kumaran Seilding V, Hoffmann JH, Enk AH, Hadaschik EN. Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: High...

• Practical issues for clinicians using high-dose intravenous immunoglobulin

  Authors:S. Khan and S. SinghFrom:Indian Journal of Dermatology (Vol. 56, Issue 1) Peer-Reviewed

  January-March 2011508 words Letter to the editor... 2030LByline: S. Khan, S. Singh Sir, We read with interest Dr Dhar's perspective on use of high-dose intravenous immunoglobulin (hd-IVIG) in dermatological conditions [sup][1] and wish to comment on some of the...

• Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy

  Authors:Satish Khadilkar, Shrikant Deshmukh, and Pramod DhondeFrom:Annals of Indian Academy of Neurology (Vol. 14, Issue 2) Peer-Reviewed

  April-June 20117,626 words Case study 1560LByline: Satish. Khadilkar, Shrikant. Deshmukh, Pramod. Dhonde The spectrum of chronic dysimmune neuropathies has widened well beyond chronic demyelinating polyradiculoneuropathy (CIDP). Pure motor (multifocal motor...

• Atopic dermatitis; Etio-pathogenesis, An overview

  Authors:Virendra Sehgal, Ananta Khurana, Vibhu Mendiratta, Deepti Saxena, Govind Srivastava, and Ashok AggarwalFrom:Indian Journal of Dermatology (Vol. 60, Issue 4) Peer-Reviewed

  July-August 20154,022 words Clinical report, Dis... 1850LByline: Virendra. Sehgal, Ananta. Khurana, Vibhu. Mendiratta, Deepti. Saxena, Govind. Srivastava, Ashok. Aggarwal Atopic dermatitis is a well-recognized clinical entity, several facets of which continue to be...

• Varizig

  From:Formulary (Vol. 48, Issue 1) Peer-Reviewed

  Jan. 201327 words Brief article 1660LVaricella zoster immune globulin preparation (Varizig, Cangene) was approved to reduce the severity of chicken pox infections in high-risk individuals when given within 4 days after exposure....

• Salivary coagulopathy and immunoglobulins in oral submucous fibrosis

  Authors:R. Pinakapani, P. Shambulingappa, and M. ShashikanthFrom:Journal of Indian Academy of Oral Medicine and Radiology (Vol. 21, Issue 2) Peer-Reviewed

  April-June 20092,772 words Clinical report Byline: R. Pinakapani, P. Shambulingappa, M. Shashikanth Aim : The etiopathogenesis of oral submucous fibrosis is still obscure. Immunological disorders have been associated with it and as the disease produces...

• Immune globulin: cerebral infarction in an elderly patient: case report

  From:Reactions Weekly (Issue 1260)

  July 11, 2009257 words Brief article, Case ... 910LA 68-year-old woman developed cerebral infarction while receiving IV immune globulin. The woman, who had a history of hypertension, experianced debility in all four extremities and facial diplegia; she was diagnosed...

• Bulletin Board

  From:Future Neurology (Vol. 4, Issue 5) Peer-Reviewed

  Sept. 20092,170 words Article 1330LA series of recent articles and editorials have examined chemical dependency and recovery, and offer a crucial overview of the challenges of this timely subject, including the potential tragedies of prescription...

• Use of intravenous immunoglobulin in the Department of Neurology at Ninewells Hospital, 2008-2009: Indications for utilization and cost-effectiveness

  Authors:Jonathan O' Riordan, Robert Swingler, and Naveed MalekFrom:Annals of Indian Academy of Neurology (Vol. 13, Issue 4) Peer-Reviewed

  October-December 20102,739 words Report 1800LByline: Jonathan. O' Riordan, Robert. Swingler, Naveed. Malek This study was designed to identify the indications for prescription of intravenous immunoglobulin (IVIg) in neurology and the cost effectiveness of this...

• HLA-Bw4-B*57 and Cw*18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil

  Authors:Edinete Melo da Silva, Angelina Xavier Acosta, Eduardo Jose Melo Santos, Eduardo Martins Netto, Denise Carneiro Lemaire, Adriano Silva Oliveira, et al.From:The Brazilian Journal of Infectious Diseases (Vol. 14, Issue 5) Peer-Reviewed

  September-October 20104,464 words Article 1650LHost genetic factors play an important role in mediating resistance to HIV-1 infection and may modify the course of infection. HLA-B alleles (Bw4 epitope; B*27 and B*57) as well as killer cell immunoglobulin-like...

• Immune globulin: chills, dyspnoea and headache: case report

  From:Reactions Weekly (Issue 1300)

  May 8, 2010125 words Brief article, Case ... 950LA 43-year-old woman developed chills, dyspnoea and headaches after 3 years of uneventful treatment with transfusions of IV immune globulin 2 g/kg, for corticosteroid-responsive recurrent-relapsing inflammatory optic...

• Hepatitis A vaccine is similar to immune globulin for postexposure prophylaxis

  From:JAAPA-Journal of the American Academy of Physicians Assistants (Vol. 21, Issue 2) Peer-Reviewed

  Feb. 2008350 words Brief article 1430LClinical question Is the hepatitis A vacine an alternative to immune globulin for postexposure prophylaxis? Bottom line Hepatitis A is a reasonable alternative to immune globulin. Advantages of the vaccine include...

• Regulation of an early developmental checkpoint in the B cell pathway by IgBeta

  Authors:Shiaoching Gong and Michel C. NussenzweigFrom:Science (Vol. 272, Issue 5260) Peer-Reviewed

  Apr. 19, 19962,996 words Article Many of the cell fate decisions in precursor B cells and more mature B cells are controlled by membrane immunoglobulin (1g) M heavy chain (m[mu]) and the Ig[alpha]-Ig[]beta signal transducers. The role of Ig[beta] in...

• Potentiation of limulin-mediated cytolysis by thiol ester-reacted forms of limulus alpha2-macroglobulin: identification of functionally important domains

  Authors:Snehasikta Swarnakar, James P. Quigley, and Peter B. ArmstrongFrom:The Biological Bulletin (Vol. 191, Issue 2) Peer-Reviewed

  Oct. 1996665 words Article The role of the Limulus alpha2-macroglobulin (LAM) protein in the plasma-based cytolytic system of the American horseshoe crab, Limulus polyphemus, was investigated in sheep erythrocytes. Native LAM had no effect on...

• Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. (Review)

  Authors:R. Gottstein and R.W.I. CookeFrom:Archives of Disease in Childhood (Vol. 88, Issue 1) Peer-Reviewed

  Jan. 20033,425 words Article Objectives: To assess the effectiveness of high dose intravenous immunoglobulin (HDIVIG) in reducing the need for exchange transfusion in neonates with proven haemolytic disease due to Rh and/or ABO incompatibility. To...

• Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer

  Authors:Charles G. Prober and Elaine E.L. WangFrom:Pediatrics (Vol. 99, Issue 3) Peer-Reviewed

  Mar. 19972,947 words Article There do not seem to be any available and effective treatments for infections caused by the respiratory syncytial virus (RSV), particularly for high-risk infants. Researchers have evaluated the use of ribavirin,...

• Losing AIDS antibodies

  Author:Deborah M. BarnesFrom:Science (Vol. 240, Issue 4858) Peer-Reviewed

  June 10, 1988845 words Article Losing AIDS Antibodies People who test positive for the AIDS virus may subsequently stop making detectable levels of antibody against it, according to a newly published study. The situation is rare and has occurred in...

• ACUTE LUNG INJURY SECONDARY TO INTRAVENOUS IMMUNOGLOBULIN (IVIG)

  Authors:Lourdes M. E. Flaminiano and Lawrence KenneyFrom:Chest (Vol. 118, Issue 4) Peer-Reviewed

  Oct. 2000778 words Article Lourdes M. E. Flaminiano, MD; Lawrence Kenney, MD--St. Elizabeth's Medical Center, Tufts University, Boston, MA Introduction: Transfusion-related acute lung injury (TRALI) is a clearly described entity which occurs...

• Health-related quality of life in patients with common variable immunodeficiency switching from intravenous to subcutaneous immunoglobulin therapy

  Authors:Mona Al-Ahmad, Ahmed Maher, and Jasmina NurkicFrom:The Egyptian Journal of Internal Medicine (Vol. 29, Issue 2) Peer-Reviewed

  April-June 20173,916 words Article 1360LByline: Mona. Al-Ahmad, Ahmed. Maher, Jasmina. Nurkic Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency disease (PID) among adults. CVID consists of two phenotypes...